Topics

Safety data on AstraZeneca anemia drug points to potential use in dialysis

09:51 EST 8 Nov 2019 | Reuters

AstraZeneca said on Friday that safety data on roxadustat underpinned the British drugmaker's hopes for the anemia drug to become a standard treatment for patients with kidney disease.

Original Article: Safety data on AstraZeneca anemia drug points to potential use in dialysis

NEXT ARTICLE

More From BioPortfolio on "Safety data on AstraZeneca anemia drug points to potential use in dialysis"

Quick Search

Relevant Topics

AstraZeneca
AstraZeneca is ranked 6th in the world, based on a pharmaceutical annual sales, which were valued at $32,800 million in 2009.  it is a global company, working in more than 100 countries, and employing 62,000 people, around a sixth of which are dedic...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...